HPRA (Ireland) awards GMP compliance to Wockhardt's Aurangabad plant
As a result of achieving GMP compliance, the shares of Wockhardt trended at Rs 589.05 per scrip, which is up by 0.43%.
Drug firm Wockhardt on Monday said the Health Products Regulatory Authority of Ireland has granted certificate of good manufacturing practices (GMP) compliance to its Aurangabad facility after an inspection.
"The Health Products Regulatory Authority of Ireland (HPRA) has granted Certificate of GMP Compliance to our Shendra, Aurangabad facility based on inspection performed from February 27, 2017 to March 3, 2017," Wockhardt said in a BSE filing.
Shares of Wockhardt were trading at Rs 589.05 per scrip on BSE, up 0.43% from previous close.